Literature DB >> 18347637

Management of Coats disease with bevacizumab in 2 patients.

Pradeep Venkatesh, Subrata Mandal, Satpal Garg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347637     DOI: 10.3129/i08-028

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


× No keyword cloud information.
  12 in total

1.  Intravitreal ranibizumab in the management of stage 2B Coats disease in a young adult Malay man.

Authors:  Swee Sew Teh; Amin Ahem; Mae-Lynn Catherine Bastion
Journal:  BMJ Case Rep       Date:  2013-06-16

2.  Role of intravitreal bevacizumab in adult onset Coats' disease.

Authors:  Neha Goel; Vinod Kumar; Anisha Seth; Usha Kaul Raina; Basudeb Ghosh
Journal:  Int Ophthalmol       Date:  2011-03-25       Impact factor: 2.031

3.  Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children.

Authors:  Shalini Kaul; Mahesh Uparkar; Kruti Mody; Jaydeep Walinjkar; Mihir Kothari; S Natarajan
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

4.  Treatment of Leukoencephalopathy With Calcifications and Cysts With Bevacizumab.

Authors:  Alex J Fay; Allison A King; Joshua S Shimony; Yanick J Crow; Jan E Brunstrom-Hernandez
Journal:  Pediatr Neurol       Date:  2017-03-23       Impact factor: 3.372

5.  Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats' disease.

Authors:  Kshitiz Kumar; Pallavi Raj; Nisha Chandnani; Amar Agarwal
Journal:  Int Ophthalmol       Date:  2018-01-29       Impact factor: 2.031

6.  Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab.

Authors:  Yu-Guang He; Hao Wang; Biren Zhao; Jason Lee; Dinesh Bahl; Jessica McCluskey
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-09       Impact factor: 3.117

Review 7.  Paediatric retinal detachment: a review.

Authors:  Raffaele Nuzzi; Carlo Lavia; Roberta Spinetta
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

8.  Intravitreal bevacizumab for pediatric exudative retinal diseases.

Authors:  Abdelrahman G Salman
Journal:  Saudi J Ophthalmol       Date:  2011-01-31

9.  Adult coats' disease successfully managed with the dexamethasone intravitreal implant (ozurdex®) combined with retinal photocoagulation.

Authors:  Sebastián Martínez-Castillo; Roberto Gallego-Pinazo; Rosa Dolz-Marco; Cristina Marín-Lambíes; Manuel Díaz-Llopis
Journal:  Case Rep Ophthalmol       Date:  2012-03-26

Review 10.  Changing paradigms of anti-VEGF in the Indian scenario.

Authors:  P Mahesh Shanmugam
Journal:  Indian J Ophthalmol       Date:  2014-01       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.